Literature DB >> 16117436

[Assessment of cardiovascular risk--PROCAM and new algorithms].

G Assmann1.   

Abstract

The absolute risk for myocardial infarction is best determined using algorithms or point schemes which have been developed on the basis of large prospective, epidemiological studies. In Germany, for instance, the PROCAM score developed in Münster is leading in this field. The role of new risk factors lies in the optimum risk prediction in patients with intermediary or high risk for myocardial infarction. It is not necessary to determine additional risk factors in low-risk-patients. At present there is however no conclusive epidemiological evidence so that the decision for investigating newer risk factors lies with the physician in charge. So far the target level for LDL cholesterol in patients with intermediate risk was set at 130 mg/dL, whereas in high risk patients LDL cholesterol should not be more than 100 mg/dL. The results of newer studies suggest that it might be appropriate to define a new category of patients with very high risk in whom the LDL cholesterol value should not exceed 70 mg/dL. This inference must however be substantiated by further studies before it becomes part of the general recommendations for treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16117436     DOI: 10.1515/BMT.2005.033

Source DB:  PubMed          Journal:  Biomed Tech (Berl)        ISSN: 0013-5585            Impact factor:   1.411


  3 in total

1.  Cardiovascular risk in patients with rheumatoid arthritis: assessment of several traditional risk parameters and a German risk score model.

Authors:  Janina Willers; Andreas Hahn
Journal:  Rheumatol Int       Date:  2011-11-16       Impact factor: 2.631

2.  [Primary prevention of coronary heart disease : Evidence-based drug treatment].

Authors:  Franziska Mühleck; Ulrich Laufs
Journal:  Herz       Date:  2020-02       Impact factor: 1.443

3.  Metabolic Syndrome in Psoriasis Is Associated With Upregulation of CXCL16 on Monocytes and a Dysbalance in Innate Lymphoid Cells.

Authors:  Lisa Schielke; Nick Zimmermann; Sarah Hobelsberger; Julian Steininger; Anne Strunk; Kristin Blau; Jessica Hernandez; Stephan Künzel; Robert Ziegenbalg; Sarah Rösing; Stefan Beissert; Susanne Abraham; Claudia Günther
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.